SCI - Spinal Cord Injury: Clinical Trials

3 trials for SCI - Spinal Cord Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Completed 1
Phase 22Completed 1, Recruiting 1

Follow SCI - Spinal Cord Injury: new trials by email Literature Review of SCI - Spinal Cord Injury trials Research Report on SCI - Spinal Cord Injury

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
CBD/CBD-A, Placebo - SCI - Spinal Cord Injury, Neuropathic Pain
Phase 1 / Phase 2CompletedUniversity of Miami62025-06-162026-08-14
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
[ 18F]3F4AP, [18F]MK6240, [11C]PIB - Demyelinating Disorders, MCI
Phase 1RecruitingYale University1052025-05-052026-09-09
Double Dose 4-AP on Functional Recovery After Spinal Cord Injury
Dalfampridine, Placebo, STDP stimulation - SCI - Spinal Cord Injury
Phase 1 / Phase 2RecruitingShirley Ryan AbilityLab272025-02-012026-06-03

Narrower conditions

Spinal Cord Injuries (3)  ·  Alzheimer Disease (1)  ·  Demyelinating Diseases (1)  ·  Multiple Sclerosis (1)  ·  Neuralgia (1)

Broader conditions

Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Spinal Cord Diseases (3)  ·  Trauma, Nervous System (3)  ·  Wounds and Injuries (3)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases (1)  ·  Dementia (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Immune System Diseases (1)  ·  Mental Disorders (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)

Interventions

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  4-Aminopyridine (1)  ·  Exercise (1)

Sponsors

Shirley Ryan AbilityLab (1)  ·  University of Miami (1)  ·  Yale University (1)

Countries

United States (3)

Top investigators

Eva Widerstrom-Noga, PhD, DDS (1)  ·  Georges El Fakhri, PhD, DABR (1)  ·  Monica Perez, PT, PhD (1)

NIH funding

P41EB022544 (1), R01AG076153 (1), R01AG085561 (1), R01EB033582 (1)